SLC2A1 plays a significant prognostic role in lung adenocarcinoma and is associated with tumor immunity based on bioinformatics analysis

BACKGROUND: The treatment of lung adenocarcinoma (LUAD) has been stuck in a bottleneck due to a number of factors. There is a pressing need for research into potential genetic markers to help drug development and improve the prognosis of patients. SLC2A1 has been reported in multiple LUAD-related pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuhang, Wen, Hui, Sun, Daqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347052/
https://www.ncbi.nlm.nih.gov/pubmed/35928739
http://dx.doi.org/10.21037/atm-22-1430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347052/
https://www.ncbi.nlm.nih.gov/pubmed/35928739
http://dx.doi.org/10.21037/atm-22-1430

Ejemplares similares